Authors:
HETHERINGTON VJ
SPARR MP
ADAMS DV
BAREITHER DJ
BURKE HB
BURNS SL
POWLESS SH
PYATAKHUGAR KM
SCUDDER RA
VENSON JN
WERTHEIMER SJ
Citation: Vj. Hetherington et al., COUNCIL ON PODIATRIC MEDICAL-EDUCATION - 78TH ANNUAL-REPORT, 1997, Journal of the American Podiatric Medical Association, 88(3), 1998, pp. 151-157
Citation: Hb. Burke et al., PREDICTING RESPONSE TO ADJUVANT AND RADIATION-THERAPY IN PATIENTS WITH EARLY-STAGE BREAST-CARCINOMA, Cancer, 82(5), 1998, pp. 874-877
Citation: Hb. Burke et De. Henson, SPECIMEN BANKS FOR CANCER PROGNOSTIC FACTOR RESEARCH, Archives of pathology and laboratory medicine, 122(10), 1998, pp. 871-874
Citation: Hb. Burke, TRENDS IN PROSTATE-CANCER SURVIVAL IN SWEDEN, 1960 THROUGH 1988 - EVIDENCE OF INCREASING DIAGNOSIS OF NONLETHAL TUMORS, Journal of the National Cancer Institute, 88(24), 1996, pp. 1864-1864
Authors:
MOGUL HR
MARSHALL M
FREY M
BURKE HB
WYNN PS
WILKER S
SOUTHERN AL
GAMBERT SR
Citation: Hr. Mogul et al., INSULIN-LIKE GROWTH FACTOR-BINDING PROTEIN-1 AS A MARKER FOR HYPERINSULINEMIA IN OBESE MENOPAUSAL WOMEN, The Journal of clinical endocrinology and metabolism, 81(12), 1996, pp. 4492-4495
Citation: Hb. Burke, BONE-MARROW TRANSPLANTATION VERSUS CHEMOTHERAPY IN NON-HODGKINS-LYMPHOMA, The New England journal of medicine, 333(11), 1995, pp. 728-728
Citation: Hb. Burke, INCREASING THE POWER OF SURROGATE END-POINT BIOMARKERS - THE AGGREGATION OF PREDICTIVE FACTORS, Journal of cellular biochemistry, 1994, pp. 278-282
Authors:
BOSTWICK DG
BURKE HB
WHEELER TM
CHUNG LWK
BOOKSTEIN R
PRETLOW TG
NAGLE RB
MONTIRONI R
LIEBER MM
VELTRI RW
GRIZZLE WE
GRIGNON DJ
Citation: Dg. Bostwick et al., THE MOST PROMISING SURROGATE END-POINT BIOMARKERS FOR SCREENING CANDIDATE CHEMOPREVENTIVE COMPOUNDS FOR PROSTATIC ADENOCARCINOMA IN SHORT-TERM PHASE-II CLINICAL-TRIALS, Journal of cellular biochemistry, 1994, pp. 283-289